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Abstract
Transplantation of testicular tissues and cells has been proposed as a future clinical option for patients who have had testicular tissue 
cryopreserved prior to receiving gonadotoxic therapies. Whilst this approach remains experimental, success using animal models and 
successful transplantation of ovarian tissue resulting in live births in female patients provides optimism for the development of 
clinical applications involving transplantation of testicular tissue in males. Careful consideration must be given to patient groups that 
may benefit from this approach in the future. Current research is focused on optimising patient selection, methods for tissue 
cryopreservation and development of transplantation techniques that might restore sperm production or future fertility in males. 
Crucially, attention must be focused on ensuring safety of transplantation, including eliminating the potential for infection or 
re-introducing malignancy. Furthermore the genetic/epigenetic integrity of any gametes generated must be ensured to allow 
generation of normal offspring. This review will provide an overview of the current status of transplantation of testicular tissue and 
cells for fertility preservation in males.
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Introduction
Cryopreservation of testicular tissue and/or cells prior to 
gonadotoxic treatment is increasingly used for fertility 
preservation in prepubertal boys (Picton et al. 2015). The 
ultimate goal is to use stored tissue to restore fertility or 
generate mature gametes for use in assisted reproduction 
technologies (ARTs). Transplantation of tissue or cells 
into the patient after treatment represents an important 
potential approach for fertility restoration. Prepubertal 
testicular cryopreservation for future transplantation has 
been advocated for a number of patient groups; however, 
there remain significant challenges before this becomes 
a reality for fertility restoration in clinical practice. 
Importantly, there are currently no studies reporting 
development of sperm following transplantation of 
prepubertal human testis tissue or spermatogonial 
stem cells (SSCs). Therefore, this approach remains 
experimental and careful consideration is required 
regarding patient selection, optimisation of surgical 
and cryopreservation procedures and development of 
effective techniques to generate sperm from transplanted 
tissue or cells. Whilst development of gametes is the 
primary objective, attention to patient safety should 
remain of paramount importance. This review will 
outline the need for fertility preservation in young males 
and the options available for specific groups of patients. 
We will focus primarily on studies involving immature 
human testis tissues and testicular transplantation in 
selected patient groups. We will describe the current 
status for each of the key stages from patient selection, 
through biopsy, to transplantation. Importantly, we will 
highlight the challenges in translating the process of 
testicular tissue cryopreservation and transplantation 
into viable future clinical applications.
Fertility preservation in males: establishing the need 
and potential options
A number of groups of young males are at risk of 
infertility in adulthood. These can be broadly classified 
into (1) those with abnormal testicular development as a 
result of an underlying clinical condition (e.g. Klinefelter, 
cryptorchidism) or (2) those in whom testicular 
development and function is considered normal but 
are due to receive gonadotoxic treatments. The latter 
group includes cancer patients and those requiring 
haematopoietic stem cell transplant (HSCT) for a variety 
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PROOF ONLYof malignant and non-malignant conditions. Whilst reduced intensity HSCT regimens have been introduced 
in childhood cancer, there is evidence to suggest that the 
deleterious effect on germ cells, as indicated by a rise in 
FSH, is similar to that of traditional regimens (Panasiuk 
et  al. 2015). Importantly, the number of patients who 
may benefit from cryopreservation of testicular tissue 
and cells has increased significantly in recent decades 
with childhood cancer survival rates now in excess of 
80% (Ward et al. 2014).
For adults at risk of infertility, semen cryopreservation 
is an effective and established option to retain the 
potential to father biological children (van Casteren 
et  al. 2008). This should be routinely offered, along 
with appropriate counselling and suitable facilities, to 
individuals facing gonadotoxic treatments (Anderson 
et al. 2015). However, fertility preservation is dependent 
on the clinician recognising the need for fertility 
preservation and providing appropriate counselling. 
This can often be a limiting factor for permitting patients 
to access fertility preservation services (Anazodo et al. 
2019). However, this option is dependent on prior 
establishment of spermatogenesis, the ability to obtain 
a semen sample and acceptability of this approach to 
the patient (Anderson et al. 2015). For patients in whom 
gametes are present, testis tissue may be removed and 
stored for future use of sperm in ART. For prepubertal 
boys at risk of infertility in whom spermatogonia are 
the only germ cell type present, an alternative approach 
is required (Fig. 1). Modification of treatment regimen 
offers the possibility of using less gonadotoxic agents 
(Viviani et al. 1985), whilst shielding the gonad may be 
used to protect the gonad from radiotherapy damage 
(Wallace & Thomson 2003). Protecting the in situ testis 
from chemotherapy-induced damage using hormone 
suppression or cytoprotective agents would also be an 
attractive option. However, whilst such approaches 
have been shown to work in animal models, no such 
therapies have been shown to work in humans (Mitchell 
et  al. 2009, Allen et  al. 2018). Therefore, removal of 
testicular tissue for future generation of sperm using in 
vitro maturation or transplantation should be considered 
in boys due to receive gonadotoxic therapies (Medrano 
et al. 2018). For the remainder of this review we will focus 
specifically on obtaining testicular tissue, for storage as 
tissue or cells and subsequent use in transplantation.
Patient selection for testicular cryopreservation
For individuals facing future infertility, counselling 
regarding the fertility risk should be provided. Options 
for fertility preservation should be discussed and offered 
where appropriate. Testicular tissue cryopreservation 
requires invasive surgery and therefore consideration 
to patient selection is required to ensure that this 
experimental approach is offered to those considered 
most likely to benefit from future clinical applications. 
Whilst criteria for patient selection have been published 
(Anderson et  al. 2015), there remains variation 
between centres and there are no definitive clinical 
recommendations for patient selection. Furthermore, 
for the majority of centres where testicular tissue 
cryopreservation is being performed, it is conducted 
as part of an ethically approved clinical research study 
(Picton et al. 2015). Currently, the majority of patients 
for whom testicular cryopreservation is offered are those 
due to receive gonadotoxic treatments for a variety of 
malignant and non-malignant conditions (Picton et al. 
2015, Ho et  al. 2017), with selection criteria often 
excluding patients with known underlying testicular 
pathology (Anderson et al. 2015, Uijldert et al. 2017).
Pre-existing testicular pathology
Pre-existing testicular pathology may have an impact 
on the potential success of subsequent transplantation. 
Cryptorchidism is a common condition resulting in 
impaired testicular growth, reduction in spermatogonial 
numbers and impaired germ cell differentiation (Kollin 
et al. 2012), resulting in an increased risk of infertility 
(Cortes et  al. 1996). Whilst testicular biopsy for 
cryopreservation at the time of orchidopexy has been 
Figure 1 Established and experimental options 
for fertility preservation in prepubertal boys. 
TESE, testicular sperm extraction; ICSI, 
intracytoplasmic sperm injection.
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PROOF ONLYadvocated in patients with cryptorchidism (Thorup et al. 2018), pre-existing impairment of germ cell development 
may affect the potential for generating sperm following 
transplantation. Furthermore, pre-existing impairment to 
the testicular somatic environment of the recipient testis 
may prevent further germ cell development. Similarly, 
for patients with Klinefelter syndrome, apparent loss 
of germ cells has been reported prior to puberty, with 
the appearance of fibrosis in peri-puberty (Van Saen 
et  al. 2018). An overall reduction in spermatogonial 
numbers have also been reported in peripubertal 
testes from Klinefelter patients compared to controls 
(Heckmann et al. 2018). However, the timing of the loss 
of spermatogonia cannot be accurately determined from 
these studies. In addition, whether the process of biopsy, 
cryopreservation and transplantation in prepubertal 
patients with cryptorchidism or Klinefelter will further 
reduce spermatogonial number compared with leaving 
the tissue in situ remains to be determined.
Whilst the vast majority of pre- and peripubertal 
patients undergoing testicular biopsy for fertility 
preservation will have spermatogonia present in the 
testis (Wyns et al. 2011), evidence for reduced number 
of spermatogonia has been reported in biopsies obtained 
from prepubertal boys with cancer who have received 
no prior treatment (Pietzak et  al. 2015). Whilst total 
germ cell numbers were either normal or increased in 
27 patients with various malignant and non-malignant 
conditions, in 5 (19%) of the patients, no Type A (dark) 
spermatogonia (putative SSCs) were identified. In 
those over the age of 6  years, primary spermatocytes 
were identified in only 9/16 (56%) patients, whereas 
these cells can be identified in a small proportion of 
seminiferous tubules in the majority of normal testes at 
this age (Nistal & Paniagua 1984).
Pre-existing testicular pathology may also be present 
in patients who have already received treatments 
previously considered to be of no (or unknown) risk 
of gonadotoxicity. Testicular cryopreservation may be 
offered to patients with sickle cell disease (SCD) due to 
undergo HSCT; however, recent evidence demonstrates 
that patients with SCD have a significantly lower 
number of spermatogonia in their testes compared with 
patients undergoing testicular biopsy for a variety of 
other indications who have not received prior treatments 
(Stukenborg et  al. 2018). Whether the reduction in 
spermatogonia is due to the hydroxyurea treatment they 
receive or the disease itself is currently unknown.
Planned treatments and regimen
For patients due to receive chemotherapy or radiotherapy, 
criteria for testicular tissue cryopreservation have been 
established based primarily on a high risk (>80%) 
of infertility after the proposed treatment (Brougham 
et  al. 2003). However, it must be recognised that the 
predicted risk of subsequent infertility in childhood 
cancer survivors is based on limited data and can only 
be considered an estimation of the actual risk. The 
high threshold for patient selection is due to the fact 
that this remains experimental (Anderson et al. 2015). 
Whilst the majority of young patients with cancer do not 
receive such treatments, for certain diagnoses, highly 
gonadotoxic regimens are used. In addition, whilst initial 
treatment may involve agents which are considered low 
risk for gonadotoxicity, subsequent treatment for relapse 
may require treatment that re-classifies the patient 
into the ‘high-risk’ category (Jahnukainen et al. 2015), 
making it challenging to limit patient selection to those 
who have received no prior chemotherapy. Selection 
criteria in some centres do therefore permit inclusion 
of patients who have already received treatments that 
are considered low risk of gonadotoxicity (Anderson 
et al. 2015).
Validation of selection criteria, to ensure that testicular 
transplantation is offered to those who are likely to 
become infertile and not to those in whom future fertility 
is retained, is an important aspect of ongoing research. 
This can be achieved by prospective follow-up of patients 
and comparison of the future fertility of those offered 
tissue cryopreservation compared to those who are not. 
Figure 2 Flow diagram for the process of fertility preservation 
involving testicular cell and tissue transplantation. Q6
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(Wallace et  al. 2014). Similar follow-up studies of 
males would include monitoring of prepubertal patients 
through puberty and biochemical assessment of gonadal 
function (e.g. LH/FSH, inhibin B) and semen analysis 
in adulthood. Whilst current selection criteria involve 
patients at high risk of gonadotoxicity, it is likely that this 
threshold will change as experimental approaches for 
fertility preservation are developed into proven clinical 
therapies; therefore, frequent re-assessment of the 
selection criteria should be employed to take account of 
new therapeutic options.
Intra-operative and early post-operative complications 
of testicular biopsy
Testicular biopsy is considered minimally invasive. 
However, for patients requiring gonadotoxic therapy, 
there may be additional risks of bleeding and infection 
as a result of their underlying condition, particularly in 
those with haematological disorders such as leukaemia 
or aplastic anaemia. Due to the experimental nature of 
this form of fertility preservation, it is important to ensure 
that the risk of complications is low. To minimise the 
anaesthetic risk, the biopsy should ideally be performed 
alongside another planned procedure requiring a 
general anaesthetic, for example, bone marrow aspirate 
or central line insertion (Picton et  al. 2015). Intra-
operative and early post-operative complications of 
testicular biopsy specifically for fertility preservation 
in prepubertal boys have been reported in a small 
number of studies (Table 1). Overall, the reported rate of 
complications is ~2% (6/284 procedures) and primarily 
consists of infection in the biopsied testis or wound 
(Ginsberg et al. 2014, Uijldert et al. 2017, Ming et al. 
2018), with a single patient reported to have had a 
wound dehiscence (Ho et al. 2017). However, this may 
underestimate the potential for specific complications 
such as post-operative testicular pain, which is only 
reported in three of the studies (Ginsberg et  al. 2010, 
2014, Ming et al. 2018). The use of retrospective data 
in some studies (Ming et  al. 2018) may also lead to 
underestimation of the complication rates. Whilst the 
evidence to date is reassuring with respect to the safety 
of testicular biopsy, larger studies using standardised 
systems for prospective recording of intra- and post-
operative complications should be considered for this 
patient group.
Long-term post-operative complications of 
testicular biopsy
The medium- to long-term effects of biopsy on testicular 
development and function have been assessed in a 
cohort of 64 boys with cancer (Uijldert et  al. 2017). 
Ultrasound scans showed the volume of both testes 
decreased in the month after the biopsy, likely due to 
chemotherapy (Uijldert et al. 2017). However, overall, 
there were no significant differences in testicular 
volume in biopsied testes compared to the contralateral 
(unbiopsied) testis at any time point following biopsy, 
suggesting that there are no additional effects of biopsy 
over the short to medium term (Uijldert et  al. 2017). 
Small fibrotic lesions were identified in the testis of 4/55 
(6.3%) boys at 12 months, the significance of which is 
unclear and requires further follow-up of these patients 
(Uijldert et al. 2017). Long-term studies are required to 
assess the effect of biopsy on testicular growth through 
puberty and the impact on testis volume in adulthood in 
this patient population.
Transport and storage of immature testicular 
biopsy material
Ensuring that the tissue remains viable during transport 
is critical. Tissue viability may be influenced by media, 
temperature, transport duration and tissue size. In a 
study using human adult tissues stored at 4°C or? room 
temperature or 37°C, temperature did not affect the 
overall morphology, viability or spermatogonial number, 
whilst apoptosis was only increased after storage at 37°C, 
Q7
Table 1 Studies reporting intra- and early post-operative complication rate from testicular biopsy for fertility preservation in prepubertal boys at 
risk of gonadotoxicity.
Patients (n) Age at harvest
Cancer 
diagnosis Biopsy details Complications Details Reference
9 7.0 ± 1.5 4/9 (45%) ≤15% 0/9 (0%) No complications Babayev et al. 
(2013)
14 5.8 (0.3–11) 14/14 (100%) ~80 mm3 0/14 (0%) No complications Ginsberg et al. 
(2010)
34 6.9 ± 4.4 27/34 (79%) ~80 mm3 2/34 (6%) 1 epididimo-orchitis, 1 torted 
appendix testis
Ming et al. 
(2018)
78 8.3 (0.5–15.5) 61/64 (92%) ≤1 mL 3/78 (3.8%) 2 wound infection Uijldert et al. 
(2017)
48 n/a 48/48 (100%) ~80 mm3 1/48 (2.1%) 1 scrotal cellulitis Ginsberg et al. 
(2014)
62 7.5 (0.9–16) 41/52 (79%) <5% 0/52 (0%) No complications Wyns et al. 
(2011)
44 7.9 (0.3–16.8) 27/44 (61%) 5–10 mm 1/44 (2.3%) 1 scrotal wound dehiscence Ho et al. (2017)
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PROOF ONLYcompared with fresh tissue (Faes & Goossens 2017). Fragment size did not affect tissue parameters, except 
for morphology which was optimally maintained in the 
larger tissue fragments (50–80 mm3) (Faes & Goossens 
2017). Media composition is also important with reduced 
tissue quality described after the addition of human 
serum albumin (HSA) (Faes & Goossens 2016). Storage 
for >5  days resulted in significant tissue deterioration 
(Faes & Goossens 2016). Validation of these results 
using human prepubertal testis tissues is required and 
should include histology, germ cell quantification and 
functional assessment of the somatic cell populations, 
including protein expression or hormone production 
following in vitro or xenotransplantation. Ideally, 
assessment of the tissue would include testing potential 
for germ cell development; however, this is challenging 
due to limited tissue availability for research.
A summary of the progress, gaps in knowledge and 
future work for patient selection and procedure for 
testicular biopsy is provided in Table 2.
Cryopreservation of prepubertal human testicular 
tissue and cells
Biopsy material may be stored as tissue fragments 
or may be dissociated to isolate specific cell types 
for cryostorage as a cell suspension. The aim of 
cryopreservation for prepubertal patients is to maintain 
the long-term viability and function of the SSCs through 
freezing, storage and thawing processes.
Cryoprotectants and methods for cryopreservation of 
prepubertal testicular tissue
Several studies have investigated methods for 
cryopreservation of testicular tissue from children and 
adults with various diagnoses (Onofre et  al. 2016, 
Zarandi et  al. 2018). Studies using animal tissues and 
limited studies using human tissues generally advocate 
a DMSO-based cryomedium for cryopreservation of 
immature tissues and a glycerol-based medium for 
mature testicular tissues (Picton et  al. 2015, Onofre 
et al. 2016, Zarandi et al. 2018). Cryopreservation may 
involve one of the three freezing methods. Slow rate 
freezing is most commonly used either as a controlled 
rate programme or using an uncontrolled approach, 
whilst vitrification involves ultra-rapid cooling aimed 
at preventing ice crystal formation which may cause 
membrane damage (Onofre et  al. 2016). For testis 
material cryopreserved as intact tissue, non-uniform 
transfer of temperature and variable penetration of the 
cryoprotectant may be important. In this regard, the 
size of tissue pieces may be important. Tissue pieces 
cryopreserved from prepubertal boys typically range 
from 1 to 9 mm3 (Keros et al. 2007, Wyns et al. 2007); 
however, a study directly measuring the impact of tissue 
size on viability of tissue post-cryopreservation has not 
been performed. Controlled slow-freezing protocols 
are most commonly used for immature human tissue 
and are associated with spermatogonial survival, whilst 
uncontrolled slow rate freezing has also resulted in 
spermatogonial survival in immature human testis tissues 
(Onofre et al. 2016, Zarandi et al. 2018). For vitrification, 
two studies have shown spermatogonial survival using 
immature human testis (Curaba et al. 2011, Poels et al. 
2013), with proliferation of spermatogonia in vitrified 
testis tissues after xenografting (Poels et al. 2013). Further 
studies are required to determine optimal methods for 
cryopreservation of prepubertal testicular tissue and 
methods for thawing following cryopreservation in 
order to ensure viability of spermatogonia for future 
clinical use.
Cryopreservation of immature testis: tissue or 
cell suspension?
For future tissue transplantation, material must be 
cryopreserved as tissue fragments, whilst for SSC 
transplantation, tissue may be stored either as whole 
tissue or as a SSC suspension. Limited data exist on 
cryopreservation of testicular cell suspensions using 
tissue from immature animals or humans (Onofre et al. 
2016, Zarandi et al. 2018) and given that tissue could 
be dissociated and SSCs isolated after cryopreservation, 
Table 2 Summary of the progress, gaps in knowledge and future work for patient selection and procedure for testicular biopsy.
Challenge Progress
Current gaps in knowledge and 
limitations Future work
Patient selection for testis 
cryopreservation
(1) Several patient groups at 
risk of infertility identified
• Absolute risks of infertility for 
patient groups
• Availability of testicular 
cryopreservation programme
• Impact of pre-existing pathology
• Experimental studies to 
determine the gonadotoxic 
effects in human tissues
• Increased access to clinical 
research programmes for 
patients at risk of infertility
• Long-term follow-up of patients 
including fertility outcomes
Procedure for testicular biopsy (1) Performed in many 
centres*
(2) Post-biopsy complications 
reported as rare
• Optimal biopsy procedure
• Long-term impact of biopsy on 
testicular function and fertility 
unknown
• Develop standardised approach 
to biopsy procedure
• Long-term studies of testicular 
function and fertility post-biopsy
*Clinical research programmes.
K R Kilcoyne and R T MitchellF6
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PROOF ONLYcurrent evidence suggests that tissue should be cryopreserved as fragments to maximise the chances of 
successful preservation of SSCs and retain all potential 
clinical options for generating gametes (Zarandi et  al. 
2018). This recommendation may change as techniques 
for cryopreservation and options for clinical use of the 
tissue evolve.
Functional assessment of cryopreserved testicular tissue 
and cells
Loss of a proportion of spermatogonia is inevitable as a 
result of the freeze-thaw process (Onofre et al. 2016); 
however, minimising cell loss and retaining function of 
the remaining SSCs should be the goal for optimisation 
of clinical cryopreservation protocols. Survival of 
spermatogonia has been described in cryopreserved 
prepubertal human testis in several studies (reviewed in 
Onofre et al. 2016, Zarandi et al. 2018). The importance 
of the efficiency of spermtagonial stem cell preservation 
in cryopreserved testicular tissue may depend on which 
method is subsequently used to generate gametes from 
the tissue. From a practical clinical perspective, for SSC 
transplant, maximising the number of viable SSCs in the 
tissue may be important for SSC transplantation in which 
the primary goal is to repopulate the testis and restore 
natural fertility. However, for testis tissue transplantation, 
removal of transplanted tissue would be required and 
therefore small numbers of sperm would be sufficient 
for use in ART.
Table  3 provides a summary of the progress, gaps 
in knowledge and future work for tissue transport, 
storage and cryopreservation for fertility preservation in 
prepubertal boys.
Generation of gametes from transplanted testicular 
tissue or cells
Transplantation of gonadal tissues
Transplantation of cryopreserved testicular tissue back 
to the patient following the completion of gonadotoxic 
therapy has been proposed for restoring fertility in 
prepubertal boys (Anderson et  al. 2015, Medrano 
et  al. 2018). This concept is supported by numerous 
reports of livebirths following cryopreservation and 
re-transplantation of human ovarian tissue in females 
who had tissue stored prior to gonadotoxic therapy 
(Donnez & Dolmans 2017), including the first livebirth 
following re-transplantation of ovarian tissue harvested 
during prepuberty (Matthews et al. 2018). Whilst there 
are clearly differences between ovarian and testicular 
development and function, this provides proof of 
principle that the general approach to removal, storage 
and re-transplantation of gonadal tissue is feasible.
Generation of functional sperm in animal models of 
testicular transplantation
For males, animal studies have provided proof of 
principle for successful generation of functional gametes 
in re-transplanted testis tissue. This has been shown 
using testis tissue from several species transplanted 
subcutaneously into castrate-recipient mice (Hutka 
et al. 2017). This includes sperm generated in immature 
non-human primate xenografts (Honaramooz et  al. 
2004, Liu et  al. 2016). In juvenile rhesus monkeys, 
xenografted tissues demonstrated accelerated initiation 
of spermatogenesis (5- and 7 months after xenografting), 
compared to ungrafted controls (Honaramooz et al. 2004, 
Ehmcke et al. 2011), which may be important considering 
that cryopreserved tissues may be re-transplanted 
in adulthood, without the long prepubertal period. 
Hormonal stimulation is also likely to play a key 
role in the sperm development within transplanted 
Table 3 Summary of the progress, gaps in knowledge and future work for tissue transport, storage and cryopreservation.
Challenge Progress
Current gaps in knowledge 
and limitations Future work
Transport and storage of 
biopsy material
(1) Studies comparing protocols are 
published for adult human adult 
tissues
• Lack of studies on 
cellular function 
• Lack of studies using 
prepubertal tissues
• Limited human tissue 
availability
• Functional studies involving cell 
development, measurement of 
hormone production 
• Determine optimal transport and 
storage conditions for prepubertal 
tissues
• Increased access to clinical research 
programmes for patients at risk of 
infertility
Cryopreservation protocol (1) Studies comparing 
cryopreservation of animal and 
human adult testis published
(2) Limited studies using prepubertal 
tissues
• Lack of studies 
comparing protocols in 
prepubertal testicular 
tissues 
• Current studies limited to 
germ cell histology and 
survival
• Conduct controlled studies 
comparing cryopreservation protocols 
in human prepubertal testis tissues
• Determine functional capacity of 
germ and somatic cell populations 
after cryopreservation
Testicular transplantation for fertility preservation F7
https://rep.bioscientifica.com Reproduction (2019) 157 F1–F14
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transplanted tissues, whilst exogenous administration 
of gonadotrophins can accelerate and sustain 
spermatogenesis in rhesus monkey testicular xenografts 
(Rathi et  al. 2008). The endocrine status of the host 
animal may also be important as indicated by a recent 
study using marmoset prepubertal testis xenografts. 
When comparing intact males with castrate males or 
intact females as host mice, the most favourable results 
for germ cell development were achieved in the intact 
males (Sharma et al. 2018).
Ultimately, the true test of functionality of sperm 
generated from transplanted tissue is generation of 
normal offspring. Birth of live offspring following 
intracytoplasmic sperm injection (ICSI) of sperm 
generated from immature mouse, rabbit and porcine 
testicular transplants has been demonstrated (Shinohara 
et  al. 2002, Schlatt et  al. 2003, Nakai et  al. 2010, 
Kaneko et  al. 2013). Importantly, blastocyst formation 
has been shown using sperm generated from immature 
rhesus Macaque xenografts (Honaramooz et al. 2004); 
and more recently, offspring have also been reported 
using sperm generated using fresh and cryopreserved 
testicular xenografts from immature cynomolgus 
monkey (Liu et al. 2016). 
Transplantation of human testicular tissue
Research into the development and function of human 
testis xenografts has increased over recent decades, 
including the use of fetal, prepubertal and adult tissues 
(Hutka et al. 2017). For prepubertal xenografts, in which 
spermatogonia are the only germ cell type identified 
in pre-biopsy tissue, the most advanced germ cell type 
identified were spermatocytes (Wyns et al. 2008, Sato 
et al. 2010, Poels et al. 2013, Van Saen et al. 2013), whilst 
for some studies no differentiation of spermatogonia 
was identified (Wyns et al. 2007, Goossens et al. 2008, 
Van Saen et  al. 2011). Differences in patient age, 
cryopreservation status of the tissue, graft size and grafting 
duration may account for the variation in germ cell 
differentiation between these studies (Hutka et al. 2017); 
however, it should be noted that the maximum duration 
of grafting was 39 weeks, which may be insufficient for 
further progression to post-meiotic stages. Several of the 
studies involving xenografting of prepubertal human 
testis tissue also xenografted tissues from (peri)pubertal 
patients, in which spermatocytes were already present 
in the pre-graft material. Spermatocytes remained the 
most advanced germ cell type in the xenografts (Van 
Saen et  al. 2011, 2013). Attempts to stimulate further 
maturation of germ cells in pre- and peripubertal 
human testis xenografts using exogenous FSH did not 
result in additional benefit in terms of germ cell survival 
or progress through meiosis (Van Saen et  al. 2013). 
Xenografts of testicular tissue containing post-meiotic 
cells consistently show regression of spermatogenesis 
and frequent degeneration of the tissue (Geens et  al. 
2006, Schlatt et al. 2006, Wyns et al. 2008), which may 
be important when considering the potential future 
application of transplantation of testicular tissue from 
pubertal patients.
Autologous testicular tissue transplantation in primates
Whilst xenografting of testicular tissue offers an 
experimental approach to develop strategies for fertility 
preservation in males, development of this approach 
for clinical use carries risks including transmission of 
zoonosis (Mitchell et al. 2009). Therefore, strategies for 
generating functional sperm in autologous transplants 
would be preferable. This has been demonstrated in 
non-human primate models including rhesus monkey 
(Jahnukainen et al. 2012) and marmoset (Luetjens et al. 
2008, Ntemou et  al. 2019), which also highlight the 
importance of the grafting site. For marmoset transplants, 
spermatogenesis occurred in orthotopic (intratesticular) 
tissues, but did not occur in tissues grafted ectopically 
(subcutaneous). This may be related to differences in 
temperature regulation at the two sites, an important 
factor for testicular function (Luetjens et  al. 2008). 
Alternatively, the presence of local testicular factors 
that may drive maturation of germ or somatic cells 
may be important. To date, no studies of autologous 
testicular tissue transplantation using human tissues 
have been reported.
Whilst autologous transplantation of testicular 
tissue fragments may ultimately provide a simple and 
effective method for generating gametes under normal 
physiological conditions, recent attention has been 
given to the use of tissue engineering to optimise the 
cellular environment and promote cell development and 
function. This may involve providing structural support 
to tissues or cells by encapsulation in hydrogels or the 
use of 3D scaffolds (Del Vento et al. 2018). Furthermore 
these structures may be used to provide local and/or 
sustained delivery of molecules such as growth factors, 
hormones or pharmaceuticals in an attempt to promote 
germ cell survival and differentiation. A limited number 
of studies have investigated the use of such strategies 
specifically using testis tissue (Del Vento et al. 2018). To 
date, no studies have demonstrated the differentiation of 
germ cells following encapsulation and transplantation 
of immature testicular cells.
Use of sperm generated by testicular 
tissue transplantation
One often overlooked aspect of the potential clinical 
application of transplantation of cryopreserved 
prepubertal testicular tissues is the potential for the 
tissue to restore natural fertility. Whilst in females, 
ovarian tissue transplanted back to the ovary is capable 
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seminiferous tubules of the transplanted tissue and the 
rete testis is required to permit passage of sperm for 
natural fertility. This connection will have been disrupted 
and therefore transport of any generated sperm through 
the reproductive tract is unlikely to occur. As a result, 
sperm generated from re-transplanted testicular tissue 
will need to be extracted for use in ART, requiring a 
further surgical procedure to remove transplanted tissue.
Spermatogonial stem cell transplantation
SSC transplantation has been shown to have the potential 
to generate functional gametes in animal models, 
providing proof of principle for the development of 
a clinical option for humans. Isolated SSC from a 
neonatal mouse testis subsequently transplanted into 
seminiferous tubules of a recipient mouse, resulted 
in generation of sperm and donor-derived offspring 
(Brinster & Avarbock 1994). SSC transplantation has 
been applied successfully for generation of offspring in 
several species (Honaramooz et al. 2003, Herrid et al. 
2009). Xenotransplantation of human SSC into the 
seminiferous tubules of immunocompromised mice has 
also been performed. Whilst not intended as a strategy 
for clinical application, xenotransplantation provides a 
model to determine whether sperm can be produced in 
transplanted human SSC. Whilst initial reports described 
no survival of donor cells (Reis et al. 2000), subsequent 
studies demonstrated colonisation of the seminiferous 
tubules and survival of SSC for up to 6 months (Nagano 
et  al. 2002, Sadri-Ardekani et  al. 2009). Transplanted 
spermatogonia were able to proliferate, but there was 
no evidence of germ cell differentiation or initiation of 
meiosis (Nagano et al. 2002). Whilst xenotransplantation 
has not proved successful for generating sperm from 
human SSC, this may relate to the lack of a compatible 
somatic environment in the host mouse testis. In such 
cases, autologous transplantation would be more likely 
to support germ cell development.
Autologous SSC transplantation in primates
Full spermatogenesis has been achieved in a primate 
model of SSC transplantation (Hermann et  al. 2012). 
SSCs were isolated and autologously transplanted into 
germ cell depleted juvenile or adult recipient testes via 
the rete testis. Spermatogenesis subsequently occurred 
in the testes of 16/17 of the recipients and donor-
derived sperm could be demonstrated in the ejaculate 
of the host. Crucially, sperm generated from allogenic 
SSC transplants were capable of fertilising rhesus 
oocytes by ICSI to produce blastocysts, demonstrating 
the functional capacity of the gametes (Hermann et al. 
2012). To date, a single report of transplantation of 
a suspension of testicular cells in humans has been 
published (Radford et al. 1999). In this study of 11 men 
with Hodgkins lymphoma, testicular tissue was removed 
prior to treatment and cryopreserved as a single cell 
suspension. Cells were transplanted back into five men 
following completion of treatment. The outcome of this 
study in terms of potential restoration of fertility has not 
been reported (Radford et al. 1999).
In vitro propagation of SSCs
A potential limiting factor for development of autologous 
SSC transplantation is the number of SSCs that can 
be obtained for transplantation. The SSC population 
is relatively rare and recent studies using human 
prepubertal testis tissue have demonstrated the limited 
quantity of spermatogonia within the testis, which may 
also be negatively influenced by underlying disease or 
previous treatments (Poganitsch-Korhonen et  al. 2017, 
Heckmann et al. 2018, Stukenborg et al. 2018) and the 
small size of biopsy material.
Whilst efficient isolation of SSC using specific cell-
surface markers is a focus for current research and may 
significantly increase the yield of human SSC (Zohni 
et al. 2012, Nickkholgh et al. 2014a, Valli et al. 2014), it 
is likely that in vitro propagation of the SSC population 
will also be required in order to generate sufficient 
SSC to restore fertility in patients. Successful long-
term culture of testicular cells from human adult testes 
resulted in >18,000-fold increase in spermatogonial 
number after 64  days in culture (Sadri-Ardekani et  al. 
2009). Furthermore, the cultured cells were able to 
colonise the seminiferous tubules of a host mouse. The 
authors calculated that the expansion of spermatogonial 
cell number in culture followed by transplantation 
would be sufficient for future clinical application 
using SSCs isolated from human prepubertal testicular 
biopsies (Sadri-Ardekani et  al. 2009). A subsequent 
study using spermatogonia from human prepubertal 
testes produced similar results, and it was calculated 
that 83 days of culture would be sufficient to repopulate 
a recipient testis for clinical application (Sadri-Ardekani 
et al. 2011). However, these calculations are based on 
extrapolation from small numbers of spermatogonia 
following transplantation and further studies including 
a larger range of patient material would be required to 
validate these findings.
A summary of the progress, gaps in knowledge and 
future work for generation of post-meiotic germ cells in 
prepubertal testicular transplants is provided in Table 4.
Safety issues for transplantation of immature 
testicular tissue and cells
Whilst progress is being made towards the development 
of clinical strategies for fertility preservation, the priority 
must always focus on ensuring safety and protecting the 
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best interests of the patient. Safety in relation to potential 
for re-introduction of tumour cells, contamination 
with infectious agents, genetic stability of the gametes 
produced and the health of resulting offspring and future 
generations are critical. The specific safety issues will 
depend on the underlying condition such as potential for 
malignant contamination of tissue obtained from patients 
with cancer. In addition, the strategy used for restoration 
of fertility might also have specific safety issues such as 
potential for contamination with infectious agents in 
xenotransplantation or genetic/epigenetic stability of in 
vitro-derived gametes.
Malignant contamination in transplanted material
For testicular tissue obtained from patients undergoing 
gonadotoxic therapies for malignancy, infiltration of 
the tissue with malignant cells is a key consideration. 
Assessment of a portion of the biopsy material should be 
routinely performed, including histological analysis and 
specific immunohistochemical, RT-PCR and/or genetic 
analysis (Dolmans et al. 2010, Rosendahl et al. 2010, 
Sorensen et al. 2014). The assessment should be based 
on the type of malignancy and can be performed prior 
to cryopreservation of the material. For haematological 
malignancies (e.g. leukaemias), the risk of malignant 
contamination of the testis is high as a result of the 
testis acting as a sanctuary site for infiltrating leukaemic 
cells. For acute lymphoblastic leukaemia (ALL), focal 
leukaemic infiltrates have been reported in 7/33 (21%) 
prepubertal boys prior to treatment (Kim et  al. 1986). 
Furthermore, late relapse may occur >10  years after 
treatment (Barredo et al. 2018).
Residual disease has been described in ovarian tissue 
cryopreserved for fertility preservation in patients with 
leukaemia (Rosendahl et  al. 2010) and histological 
analysis alone may fail to identify the presence of 
malignant cells (Dolmans et  al. 2010). Whilst the risk 
for solid tumours may be lower than for haematological 
malignancy, demonstration of a previously unidentified 
foci of Ewing’s Sarcoma in an ovarian tissue biopsy 
indicates the potential for malignant contamination, 
even in low-risk cases (Sorensen et al. 2014).
It has been shown in a rat model that as few as 20 
leukaemic cells in a fresh or cryopreserved testicular 
cell suspension can result in relapse following testicular 
injection in a recipient host (Jahnukainen et al. 2001). 
Elimination of malignant cells from tissues may be 
achieved by dissociating into a single-cell suspension 
and removing malignant cells by fluorescent-activated 
cell sorting (FACS) prior to transplantation. Studies in 
leukaemic mice have demonstrated survival of mice 
and the generation of functional gametes in the host 
testis, providing proof of principle for this approach 
(Fujita et al. 2005). However, a subsequent study aiming 
to remove malignant cells from a mixed suspension of 
human testicular cells and an ALL cell line via FACS 
and/or MACS demonstrated evidence for persistent 
malignant contamination by PCR in 9/10 patients 
(Geens et al. 2007).
A study involving prepubertal non-human primate 
testis used FACS to isolate spermatogonia from a 
mixed suspension of testicular and leukaemic cells 
(Hermann et al. 2011). As expected, transplantation of 
the leukaemic cell (CD90−/CD45+) population resulted 
in the formation of tumours in host mice. However, 
transplantation of the putative SSC population (CD90−/
CD45+) also resulted in the formation of tumours, and 
purity checks of the cell population revealed 0.1% 
contamination with leukaemic cells (CD90−/CD45+) 
(Hermann et  al. 2011). Refinement of cell-sorting 
techniques, with post-sorting purity checks, improved 
Table 4 Summary of the progress, gaps in knowledge and future work for generation of post-meiotic germ cells in prepubertal testicular 
transplants.
Challenge Progress
Current gaps in knowledge 
and limitations Future work
Generation of post-meiotic 
germ cells in tissue 
transplants
(1) Successful generation of functional 
sperm in animal models of xeno- and 
autologous transplantation (includes 
non-human primate)
• Ethics required for 
generation of human 
gametes in research
• No studies involving 
human tissues have 
generated sperm
• Limited human tissue 
availability
• Obtain ethical approvals for 
research involved in generation of 
human gametes
• Clinical trial of autologous 
transplantation of (non-malignant) 
cells
• Increase access to clinical 
research programmes
Generation of post-meiotic 
germ cells in SSC 
transplants
(1) Successful generation of functional sperm 
in animal models of xeno- and 
autologous transplantation (includes 
non-human primate)
(2) Successful propagation of human 
prepubertal spermatogonia
• Ethics required for 
generation of human 
gametes in research
• No studies involving 
human tissues have 
generated sperm
• Limited human tissue 
availability
• Effect of long-term 
culture on function and 
safety of human germ 
cells
• Obtain ethical approvals for 
research involved in generation of 
human gametes
• Clinical trial of autologous 
transplantation of (non-malignant) 
cells
• Increase access to clinical 
research programmes
• Determine functional capacity of 
germ cells following in vitro 
propagation and transplantation
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with similar results reported in a subsequent study 
involving isolation of spermatogonia using the EpCAM 
cell-surface marker (Dovey et al. 2013).
Xenografting of cryopreserved testicular tissue has 
been proposed as an alternative method of detecting 
malignant contamination within the tissue (Hou et  al. 
2007). Transplantation of testicular tissues from rats 
with terminal leukaemia resulted in the development 
of leukaemia in the host animals (Hou et  al. 2007). 
However, whether this approach can be used to detect 
contamination in tissues containing very few malignant 
cells or whether this can also be applied to human tissue 
is unknown. Furthermore, the duration of xenografting 
used for such studies may not be sufficient to determine 
the potential for late relapse from leukaemia as has been 
described in humans many years after completion of 
treatment (Barredo et al. 2018).
In vitro propagation of testicular cell suspensions has 
been proposed as a method to simultaneously develop 
spermatogonia whilst removing potential contamination 
with malignant cells (Sadri-Ardekani et al. 2014). In this 
pilot study, the maximum survival of ALL cells in culture 
was 14  days and for co-culture with spermatogonia, 
the ALL cells did not survive beyond 26  days (Sadri-
Ardekani et al. 2014). These results suggest that in vitro 
propagation of SSCs for future transplantation may also be 
used to decontaminate the suspension of malignant cells 
prior to transplant. Elimination of malignant cells using 
nanoparticles delivering chemotherapy has recently 
been described for neonatal mouse spermatogonial cell 
co-cultures (Shabani et al. 2018). Further validation of 
methods to eliminate malignant cells from testicular 
tissues or cultures is required before clinical application 
of transplantation can be attempted.
Contamination of testicular tissue or cells with 
infectious agents
Harvesting, cryopreservation, propagation and 
transplantation of human prepubertal testicular tissues 
should be conducted according to good clinical practice 
guidelines to ensure a sterile environment at all times 
(Pacchiarotti et al. 2013). Sterility testing should also be 
performed to identify potential tissue infection before it 
is transplanted. For xenografts, additional considerations 
relating to transmission of zoonosis must be considered 
(Mohiuddin 2007). Tissues xenografted into a host animal 
of a different species may result in the transmission of 
viruses or incorporation of retroviruses (Chapman & 
Bloom 2001), as has been demonstrated in the case of 
porcine endogenous retrovirus (PERV) (Patience et  al. 
1997). Previously unidentified infectious agents should 
be considered as has been shown historically for example 
prion disease in Creutzfeldt-Jakob disease (Chapman & 
Bloom 2001). The risks of infection, rejection and the 
need for immunosuppression make re-transplantation of 
xenografts back into the patients unfeasible for clinical 
application. Therefore, use of xenografted testicular 
tissues from prepubertal patients would be limited to 
extraction of sperm generated in the xenograft for use 
in ART, although further studies would be required to 
ensure the safety of such an application.
Genetic/epigenetic stability of gametes from 
transplanted testicular tissues and cells
For gametes generated following transplantation of 
testicular tissue or cells, ensuring genetic and epigenetic 
stability of these cells is important. Theoretically 
such changes may occur as a result of manipulation 
involved in cryopreservation, dissociation, culture or 
transplantation. Evidence indicating genetic/epigenetic 
stability in mouse SSC has been shown following 
cryopreservation (for 14  years), transplant and ICSI 
(Wu et  al. 2012). No abnormalities were identified 
in the offspring in terms of chromosomal deletions/
duplications. Furthermore global DNA methylation 
was unchanged, as was methylation at two imprinted 
loci (Wu et  al. 2012). Similarly, chromosome number 
was normal in epididymal sperm obtained following 
transplantation of SSC from immature mouse testis into a 
germ cell-depleted host (Goossens et al. 2010). A study 
comparing epigenetic modifications in mouse germ 
cells after transplantation of tissue or cells demonstrated 
a similar DNA methylation profile in both groups and 
in fertile controls; however, expression of histone 
modifications were altered in elongated spermatids 
from the SSC transplant group (Goossens et al. 2011). 
Evaluation of first- and second-generation offspring 
following transplantation of immature mouse SSC 
found no effect on growth of the offspring or on DNA 
methylation of selected imprinted and non-imprinted 
loci (Goossens et al. 2009).
Genetic and epigenetic stability of sorted and cultured 
human SSCs from two adults with prostate cancer has also 
been reported (Nickkholgh et al. 2014b). Chromosomal 
analysis revealed no aneuploidy following culture; 
however, there were changes in the methylation status of 
several imprinted genes (Nickkholgh et al. 2014b). The 
significance of this remains to be determined, but could 
reflect changes in methylation in the SSCs. Alternatively, 
it may reflect changes in somatic cell proportions within 
the cultures, as has been demonstrated in testicular 
cultures from marmoset tissues (Langenstroth-Rower 
et  al. 2017). Further studies of genetic/epigenetic 
stability of SSCs will require analysis of cells obtained 
from prepubertal testis throughout the process from 
isolation through to transplantation with assessment of 
offspring and subsequent generations. This is likely to 
require extensive use of animal studies in addition to 
long-term follow-up in human populations.
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Table  5 includes a summary of the progress, gaps 
in knowledge and future work ensuring safety of 
prepubertal testicular transplantation.
Conclusion
Significant progress has been made towards the 
development of clinical options for fertility preservation 
in humans using transplantation of testicular tissues 
and cells. Animal models provide proof of principle for 
autologous transplantation of SSC or testicular tissues to 
generate gametes for the production of healthy offspring. 
Current research is aimed at translating this knowledge 
into clinical applications, particularly for patients due to 
receive gonadotoxic therapies. A number of challenges 
remain before this could be applied clinically, the most 
significant of which include post-meiotic differentiation 
of germ cells and ensuring the safety of transplantation 
approaches for the patient and resulting offspring. 
The recent interest in tissue engineering of artificial 
gonads in which the cellular composition and structure 
can be designed to support spermatogenesis may 
provide additional options, particularly for those with 
underlying testicular abnormality. Experience and 
knowledge gained from previous studies, coupled with 
the successful development of ovarian transplantation 
for fertility preservation in females, provide optimism 
that fertility preservation using transplantation of 
cryopreserved testicular tissue and cells may soon be a 
viable clinical option for prepubertal boys.
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